Literature DB >> 7605206

Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells.

O Scheglovitova1, V Scanio, S Fais, S Papadia, I Abbate, C Castilletti, F Dianzani, M R Capobianchi.   

Abstract

Human umbilical vein endothelial cells (HUVEC) can be abortively infected with HIV-1, but virus production is rescued by the addition of T cells. Monoclonal antibody (Mab) to ICAM-1, but not its Fab' fragment or MAbs to LFA-1 and PECAM-1, increases HIV-1 infection of HUVEC by enhancing HIV-1 absorption. Enhancement by anti ICAM-1 is probably due to a bridging effect different from the ADE mediated by anti-gp120 that involves FcR or CR-mediated capture of the virus-antibody complex. Since antibodies to cell membrane molecules are present in HIV-1 infected patients, the ADE mediated by such a mechanism can be important in AIDS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605206     DOI: 10.1007/BF01314971

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

Review 1.  Circulating adhesion molecules in disease.

Authors:  A J Gearing; W Newman
Journal:  Immunol Today       Date:  1993-10

2.  The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

Authors:  J Homsy; M Meyer; M Tateno; S Clarkson; J A Levy
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

3.  Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials.

Authors:  J R Mascola; B J Mathieson; P M Zack; M C Walker; S B Halstead; D S Burke
Journal:  AIDS Res Hum Retroviruses       Date:  1993-12       Impact factor: 2.205

4.  Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

Authors:  M B Lawrence; T A Springer
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

5.  Synthetic peptide analogs of intercellular adhesion molecule 1 (ICAM-1) inhibit HIV-1 replication in MT-2 cells.

Authors:  J V Fecondo; N C Pavuk; K A Silburn; D M Read; A S Mansell; A W Boyd; D A McPhee
Journal:  AIDS Res Hum Retroviruses       Date:  1993-08       Impact factor: 2.205

6.  CD4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells.

Authors:  O Scheglovitova; M R Capobianchi; G Antonelli; D Guanmu; F Dianzani
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

Authors:  L O Arthur; J W Bess; R C Sowder; R E Benveniste; D L Mann; J C Chermann; L E Henderson
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

8.  Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.

Authors:  R J Orentas; J E Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

9.  Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patients.

Authors:  M O Borghi; C De Santis; W Barcellini; L Lopalco; C Fain; A Lazzarin; A G Siccardi; P L Meroni; C Zanussi; A Beretta
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-10

10.  Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Authors:  W E Robinson; D C Montefiori; W M Mitchell
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

View more
  4 in total

1.  Human parainfluenza virus type 3 upregulates ICAM-1 (CD54) expression in a cytokine-independent manner.

Authors:  J Gao; S Choudhary; A K Banerjee; B P De
Journal:  Gene Expr       Date:  2000

2.  Equine endothelial cells support productive infection of equine infectious anemia virus.

Authors:  W Maury; J L Oaks; S Bradley
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

3.  Divergent responses of different endothelial cell types to infection with Candida albicans and Staphylococcus aureus.

Authors:  Kati Seidl; Norma V Solis; Arnold S Bayer; Wessam Abdel Hady; Steven Ellison; Meredith C Klashman; Yan Q Xiong; Scott G Filler
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

Review 4.  Hidden in plain sight: The effects of BCG vaccination in the COVID-19 pandemic.

Authors:  Eman A Toraih; Jessica A Sedhom; Titilope M Dokunmu; Mohammad H Hussein; Emmanuelle M L Ruiz; Kunnimalaiyaan Muthusamy; Mourad Zerfaoui; Emad Kandil
Journal:  J Med Virol       Date:  2020-12-17       Impact factor: 20.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.